Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Smith & Nephew plc | 1 | 0 | 0 | 0 | €12.81 | - | - |
| Veeva Systems A | 2 | 0 | 0 | 0 | €168.50 | - | - |
| HCA Holdings Inc. | 31 | 0 | 4 | 0 | €293.00 | €303.80 | 3.685% |
| AbbVie Inc. | 43 | 0 | 21 | 0 | €155.42 | €176.30 | 13.435% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 1 | 0 | €76.76 | €103.66 | 35.042% |
| Sarepta Therapeutics | 13 | 0 | 12 | 0 | €138.95 | €180.00 | 29.543% |
| Genmab A/S | 1 | 0 | 1 | 0 | €237.60 | €250.00 | 5.219% |
| Fresenius SE & Co. KGaA | 7 | 0 | 4 | 0 | €28.80 | €34.50 | 19.792% |
| Hologic Inc. | 18 | 0 | 1 | 0 | €69.00 | €83.99 | 21.730% |
| Laboratory Corp. Of America (labcorp) | 12 | 0 | 1 | 0 | €197.00 | €237.94 | 20.782% |
| Idexx Laboratories Inc. | 13 | 0 | 1 | 0 | €442.00 | €550.70 | 24.594% |
| Eli Lilly Corp. | 79 | 0 | 30 | 0 | €863.30 | €900.00 | 4.251% |
| Sanofi S.A. ADR | 9 | 0 | 0 | 0 | €46.40 | - | - |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €141.85 | €165.00 | 16.320% |
| Sanofi S.A. | 22 | 0 | 19 | 0 | €91.98 | €100.00 | 8.719% |
| Intuitive Surgical Inc | 40 | 0 | 7 | 0 | €409.05 | €397.79 | -2.754% |
| EssilorLuxottica SA | 3 | 0 | 0 | 0 | €197.20 | €204.50 | 3.702% |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
| Fresenius Medical Care AG & Co KGaA ST | 4 | 0 | 0 | 0 | €35.77 | €50.00 | 39.782% |
| Abbott Laboratories | 21 | 0 | 3 | 0 | €93.98 | €115.05 | 22.420% |
| UCB S.A. | 1 | 0 | 0 | 0 | €144.15 | - | - |
| Cigna Corp. | 20 | 0 | 2 | 0 | €303.70 | €351.57 | 15.763% |
| Boston Scientific | 62 | 0 | 14 | 0 | €71.00 | €76.75 | 8.103% |
| Thermo Fisher Scientific Inc. | 46 | 0 | 19 | 0 | €491.80 | €560.75 | 14.020% |
| Teva Pharmaceutical Industries Ltd ADR | 15 | 0 | 1 | 0 | €14.65 | €18.53 | 26.512% |